Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 354 shares at $28.80 ($10K) on 2016-02-25, disclosed to the SEC on 2016-02-26.
Scheduled sale ($10k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.80 | 254 | $7K | 70.8% |
| 2 | $30.15 | 100 | $3K | 29.2% |
| Total | $29.18 avg | 354 | $10K | 100% |
| Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |
| HTWR | SELL | 2015-02-10 | $42K | — | Filing → |